Novavax's (NVAX) protein-based COVID-19 vaccine gets recommendation for full marketing authorization in COVID-19 patients from European Medicines Agency.
Novavax stock is on the rise after announcing a cost-cutting plan and bullish sales guidance. Is NVAX stock a buy or a sell today?
Novavax and Ocugen fell behind in the coronavirus vaccine race and their shares have plummeted. Now, both companies have revised their strategies.

Novavax: Sell The Covid Rips

03:17pm, Wednesday, 24'th May 2023
Novavax, Inc. continues to rally on positive Covid news, but the vaccine demand continues to trend lower. The biotech now plans to slash operating expenses by up to 50% from 2022 levels in a further s
TipRanks' analyst ranking service ranks the top Wall Street firms of the past decade.

The 3 Best Stocks to Short in May 2023

07:03am, Friday, 19'th May 2023
One of the places to find the best stocks to short are by viewing the Short Interest tables of major financial publications like MarketWatch and the Wall Street Journal. It's there you find the heavil
The world's foremost artificial intelligence stock trading algorithm, An-E, predicts that Novavax (NASDAQ: NVAX ) stock will gain 7% by June 15. An-E (pronounced Annie) has made this kind of predictio
Novavax (NASDAQ: NVAX) stock price has dropped in the past five straight days as concerns about the company's outlook darkened. The shares were trading at $7.65, which was about 32% below this month's
Sizable declines in the stock market can present ideal opportunities for investors to pounce. Wall Street analysts believe these downtrodden companies can soar in the quarters and years to come.

Up 40% in 1 Day, Is Novavax Stock a Buy Now?

09:00am, Monday, 15'th May 2023
Novavax has a game plan to try to avoid going out of business. That plan is going to involve chopping a lot of costs.

Is Novavax Finally Turning Things Around?

08:59am, Monday, 15'th May 2023
Vaccine developer Novavax Inc. NASDAQ: NVAX stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious diseases, including COVID-19, influenza, respira
Novavax, Inc. (NASDAQ:NVAX ) BofA Securities 2023 Health Care Conference May 11, 2023 1:00 PM ET Company Participants John Jacobs - President & Chief Executive Officer Filip Dubovsky - President-Resea
Novavax's John C. Jacobs detailed his plan to cut costs and manage cash flow.
Fueling the flames of speculative fervor, business news agency CNBC released its list of the most heavily shorted public securities. Topping the list stood used-car retailer Carvana (NYSE: CVNA ).
Novavax (NVAX) reports dismal Q1 earnings results, as earnings and revenues miss estimates. However, shares rise on the back of encouraging 2023 guidance and cost-reduction initiatives.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE